B-cell lymphoma gene regulatory networks: Biological consistency among inference methods

Frontiers in Genetics

Volumn 4, Issue DEC, 2013, Pages

  Simoes, Ricardo de Matos ^a   Dehmer, Matthias ^b   Emmert Streib, Frank ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY FOR HEALTH SCIENCES   (Austria)

Author keywords

Aracne; BC3Net; C3Net; Gene regulatory network; GPEA; Statistical inference

Indexed keywords

EID: 84892411193     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00281     Document Type: Article

References (59)

1. Albizu, L., Moreno, J., Gonzalez-Maeso, J., and Sealfon, S. (2010). Heteromerization of g protein-coupled receptors: relevance to neurological disorders and neurotherapeutics. CNS Neurol. Disord. Drug Targets 9, 636-650. doi: 10.2174/187152710793361586.
2. Altay, G., and Emmert-Streib, F. (2010). Inferring the conservative causal core of gene regulatory networks. BMC Syst. Biol. 4:132. doi: 10.1186/1752-0509-4-132.
3. Altay, G., and Emmert-Streib, F. (2011). Structural Influence of gene networks on their inference: analysis of C3NET. Biol. Dir. 6:31. doi: 10.1186/1745-6150-6-31.
4. Balendiran, G., Dabur, R., and Fraser, D. (2004). The role of glutathione in cancer. Cell Biochem. Funct. 22, 343-352. doi: 10.1002/cbf.1149.
5. Barrett, T., Troup, D., Wilhite, S., Ledoux, P., Evangelista, C., Kim, I., et al. (2011). NCBI GEO: archive for functional genomics data sets-10 years on. Nucleic Acids Res. 39, D1005-D1010. doi: 10.1093/nar/gkq1184.
6. Basso, K., Margolin, A., Stolovitzky, G., Klein, U., Dalla-Favera, R., and Califano, A. (2005). Reverse engineering of regulatory networks in human B cells. Nat. Genet. 37, 382-390. doi: 10.1038/ng1532.
7. Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B (Methodol.) 57, 125-133.
8. Bovolenta, L., Acencio, M., and Lemke, N. (2012). HTRIdb: an open-access database for experimentally verified human transcriptional regulation interactions. BMC Genomics 13:405. doi: 10.1186/1471-2164-13-405.
9. Breiman, L. (1996). Bagging Predictors. Mach. Learn. 24, 123-140. doi: 10.1007/BF00058655.
10. Carlson, M. (2013). org.Hs.eg.db: Genome wide annotation for Human. R package version 2.9.0.
11. Cover, T., and Thomas, J. (1991). Information Theory. New York, NY: John Wiley & Sons, Inc.
12. D'Alessandro, V., Muscarella, L., laTorre, A., Bisceglia, M., Parrella, P., Scaramuzzi, G., et al. (2010). Molecular analysis of the HuD gene in neuroendocrine lung cancers. Lung. Cancer 67, 69-75. doi: 10.1016/j.lungcan.2009.03.022.
13. Davison, A., and Hinkley, D. (1997). Bootstrap Methods and Their Application. New York, NY: Cambridge University Press. doi: 10.1017/CBO9780511802843.
14. de Matos Simoes, R., Dehmer, M., and Emmert-Streib, F. (2013). Interfacing cellular networks of S. cerevisiae and E. coli: Connecting dynamic and genetic information. BMC Genomics 14:324. doi: 10.1186/1471-2164-14-324.
15. de Matos Simoes, R., and Emmert-Streib, F. (2011). Influence of statistical estimators of mutual information and data heterogeneity on the inference of gene regulatory networks. PLoS ONE 6:e29279. doi: 10.1371/journal.pone.0029279.
16. de Matos Simoes, R., and Emmert-Streib, F. (2012). Bagging statistical network inference from large-scale gene expression data. PLoS ONE 7:e33624. doi: 10.1371/journal.pone.0033624.
17. de Matos Simoes, R., Tripathi, S., and Emmert-Streib, F. (2012). Organizational structure and the periphery of the gene regulatory network in B-cell lymphoma. BMC Syst. Biol. 6:38. doi: 10.1186/1752-0509-6-38.
18. Dudoit, S., and van der Laan, M. (2007). Multiple Testing Procedures with Applications to Genomics. New York; London: Springer.
19. Efron, B., and Tibshirani, R. (1994). An Introduction to the Bootstrap. New York, NY:Chapman and Hall/CRC.
20. Emmert-Streib, F. (2013). Influence of the experimental design of gene expression studies on the inference of gene regulatory networks: environmental factors. PeerJ 1:e10. doi: 10.7717/peerj.10.
21. Emmert-Streib, F., and Dehmer, M. (2011). Networks for Systems Biology: conceptual Connection of Data and Function. IET Syst. Biol. 5:185. doi: 10.1049/iet-syb.2010.0025.
22. Emmert-Streib, F., Glazko, G., Altay, G., and de Matos Simoes, R. (2012). Statistical inference and reverse engineering of gene regulatory networks from observational expression data. Front. Genet. 3:8. doi: 10.3389/fgene.2012.00008.
23. Esposito, G., Rapacciuolo, A., Prasad, S. V. N., and Rockman, H. A. (2002). Cardiac hypertrophy: role of g protein-coupled receptors. J. Card. Fail. 8(6 Part B), S409-S414. doi: 10.1054/jcaf.2002.129283.
24. Friedman, N. (2004). Inferring cellular networks using probabilistic graphical models. Science 303, 799-805. doi: 10.1126/science.1094068.
25. Ghosh, S., and Basu, A. (2012). Network medicine in drug design: implications for neuroinflammation. Drug Discov. Today 17, 600-607. doi: 10.1016/j.drudis.2012.01.018.
26. Goh, K., Cusick, M., Valle, D., Childs, B., Vidal, M., and Barabasi, A. (2007). The human disease network. Proc. Natl. Acad. Sci. U.S.A. 104, 8685-8690. doi: 10.1073/pnas.0701361104.
27. Gomez, D., Ripoll, G., Giron, S., and Alonso, D. (2006). Desmopressin and other synthetic vasopressin analogues in cancer treatment. Bull. Cancer 93, E7-E12.
28. Gultekin, S., Rosai, J., Demopoulos, A., Graus, Y., Posner, J., Dalmau, J., et al. (2000). Hu immunolabeling as a marker of neural and neuroendocrine differentiation in normal and neoplastic human tissues: assessment using a recombinant anti-Hu Fab Fragment. Int. J. Surg. Pathol. 8, 109-117. doi: 10.1177/106689690000800205.
29. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70. doi: 10.1016/S0092-8674(00)81683-9.
30. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674. doi: 10.1016/j.cell.2011.02.013.
31. Hopkins, A. L. (2008). Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4, 682-690. doi: 10.1038/nchembio.118.
32. Ildirim, M., Goh, K.-I., Cuisick, M., Barabasi, A.-L., and Vidal, M. (2007). Drug-target network. Nat. Biotechnol. 25, 1119-1126. doi: 10.1038/nbt1338.
33. Jeong, H., Mason, S., Barabasi, A., and Oltvai, Z. (2001). Lethality and centrality in protein networks. Nature 411, 41-42. doi: 10.1038/35075138.
34. Keir, S., Friedman, H., Reardon, D., Bigner, D., and Gray, L. (2013). Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model. J. Neurooncol. 111, 97-102. doi: 10.1007/s11060-012-0995-0.
35. Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., et al. (2011). DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 39, D1035-D1041. doi: 10.1093/nar/gkq1126.
36. Lappano, R., and Maggiolini, M. (2011). G protein-coupled receptors: novel targets for drug discovery in cancer. Nat. Rev. Drug. Discov. 10, 47-60. doi: 10.1038/nrd3320.
37. Lehman, E. (2005). Testing Statistical Hypotheses. New York, NY: Springer.
38. Marchini, S., Poynor, E., Barakat, R., Clivio, L., Cinquini, M., Fruscio, R., et al. (2012). The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer. Clin. Cancer Res. 18, 4313-4324. doi: 10.1158/1078-0432.CCR-12-0037.
39. Margolin, A., and Califano, A. (2007). Theory and limitations of genetic network inference from microarray data. Ann. N.Y. Acad. Sci. 1115, 51-72. doi: 10.1196/annals.1407.019.
40. Margolin, A., Nemenman, I., Basso, K., Wiggins, C., Stolovitzky, G., Dalla Favera, R., et al. (2006). ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 7(Suppl. 1):S7. doi: 10.1186/1471-2105-7-S1-S7.
41. Maslov, S., and Sneppen, K. (2002). Specificity and stability in topology of protein networks. Science 296, 910-913. doi: 10.1126/science.1065103.
42. Meyer, P., Kontos, K., and Bontempi, G. (2007). Information-theoretic inference of large transcriptional regulatory networks. EURASIP J. Bioinform. Syst. Biol. 2007:79879. doi: 10.1155/2007/79879.
43. Newman, M. (2002). Assortative mixing in networks. Phys. Rev. Lett. 89:208701. doi: 10.1103/PhysRevLett.89.208701.
44. Newman, M. (2010). Networks: An Introduction. Oxford: Oxford University Press.
45. Olsen, C., Meyer, P., and Bontempi, G. (2009). On the impact of entropy estimator in transcriptional regulatory network inference. EURASIP J. Bioinform. Syst. Biol. 2009:308959. doi: 10.1155/2009/308959.
46. Razick, S., Magklaras, G., and Donaldson, I. (2008). iRefIndex: a consolidated protein interaction database with provenance. BMC Bioinformatics 9:405. doi: 10.1186/1471-2105-9-405.
47. Schaffter, T., Marbach, D., and Floreano, D. (2011). GeneNetWeaver: in silico benchmark generation and performance profiling of network inference methods. Bioinformatics 27, 2263-2270. doi: 10.1093/bioinformatics/btr373.
48. Shamash, J., Salam, A., Davies, D., Williams, A., Joel, S., and Lister, T. (1998). In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma. Br. J. Cancer. 77, 1598-1603. doi: 10.1038/bjc.1998.262.
49. Sheskin, D. J. (2004). Handbook of Parametric and Nonparametric Statistical Procedures. 3rd Edn. Boca Raton, FL: RC Press.
50. Simpson, W. (1985). The calcium channel blocker verapamil and cancer chemotherapy. Cell Calcium 6, 449-467. doi: 10.1016/0143-4160(85)90021-1.
51. Striessnig, J., Bolz, H., and Koschak, A. (2010). Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels. Pflugers Arch. 460, 361-374. doi: 10.1007/s00424-010-0800-x.
52. Van den Bulcke, T., Van Leemput, K., Naudts, B., van Remortel, P., Ma, H., Verschoren, A., et al. (2006). SynTReN: a generator of synthetic gene expression data for design and analysis of structure learning algorithms. BMC Bioinformatics 7:43. doi: 10.1186/1471-2105-7-43.
53. Watts, D., and Strogatz, S. (1998). Collective dynamics of 'small-world' networks. Nature 393. 440-442. doi: 10.1038/30918.
54. Werhli, A., Grzegorczyk, M., and Husmeier, D. (2006). Comparative evaluation of reverse engineering gene regulatory networks with relevance networks, graphical gaussian models and bayesian networks. Bioinformatics 22, 2523-2531. doi: 10.1093/bioinformatics/btl391.
55. Wille, A., Zimmermann, P., Vranova, E., Furholz, A., Laule, O., Bleuler, S., et al. (2004). Sparse graphical gaussian modeling of the isoprenoid gene network in arabidopsis thaliana. Genome Biol. 5:R92. doi: 10.1186/gb-2004-5-11-r92.
56. Yip, K. Y., Alexander, R. P., Yan, K.-K., and Gerstein, M. (2010). Improved reconstruction of in silico gene regulatory networks by integrating knockout and perturbation data. PLoS ONE 5:e8121. doi: 10.1371/journal.pone.0008121.
57. Young, G. A., and Smith, R. L. (2005). Essentials of Statistical Inference. Cambridge: Cambridge University Press. doi: 10.1017/CBO9780511755392.
58. Zhang, H., and Singer, B. H. (2010). Recursive Partitioning and Applications. New York, NY: Springer. doi: 10.1007/978-1-4419-6824-1.
59. Zhang, X., Zhao, X.-M., He, K., Lu, L., Cao, Y., Liu, J., et al. (2011). Inferring gene regulatory networks from gene expression data by PC-algorithm based on conditional mutual information. Bioinformatics 28, 98-104. doi: 10.1093/bioinformatics/btr626.